SCHEMBL1285037

SCHEMBL1285037

CCN(C(=O)O)[C@H]1CCN(c2ccc(F)c3c2CC(C)O3)C1

nearest known ligand 0.36

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
GAA P10253 2/20 0.36
HPGD P15428 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
PARP1 P09874 2/20 0.34
HTR2A P28223 1/20 0.33
NOTUM Q6P988 1/20 0.32
WDR5 P61964 1/20 0.32
UBE2M P61081 4/20 0.32
DCUN1D1 Q96GG9 4/20 0.32
USP30 Q70CQ3 1/20 0.32
MAOB P27338 1/20 0.32
PDK2 Q15119 1/20 0.32
MTNR1A P48039 2/20 0.32
MTNR1B P49286 2/20 0.32
NPY2R P49146 1/20 0.31
KDM4E B2RXH2 1/20 0.31
ALDH1A1 P00352 1/20 0.31
CCR5 P51681 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1285096 0.87 NOTUM (0.34) GAAHPGDSMN1; SMN2PARP1NOTUM
SCHEMBL1284765 0.84 NOTUM (0.32) GAAHPGDSMN1; SMN2PARP1NOTUM
SCHEMBL3428772 0.77 MTNR1A (0.43) USP30MTNR1AMTNR1B
SCHEMBL1285841 0.75 MTNR1A (0.57) GAAHPGDSMN1; SMN2MTNR1AMTNR1B
SCHEMBL1284713 0.75 MTNR1A (0.57) MTNR1AMTNR1B
SCHEMBL1285176 0.75 MTNR1A (0.53) MTNR1AMTNR1B
SCHEMBL1285217 0.75 F10 (0.35) GAAPARP1KDM4E
SCHEMBL1696512 0.74 MTNR1A (0.42) MTNR1AMTNR1B
SCHEMBL1285050 0.74 MTNR1A (0.54) USP30MTNR1AMTNR1B
SCHEMBL1285322 0.74 MTNR1A (0.51) MTNR1AMTNR1B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2443108-A1 1-(2-ALKYL-2,3-DIHYDRO-BENZOFURAN-4-YL)-PYRROLIDIN-3-YLAMINE ACYL COMPOUNDS Ferrer Internacional, S.A. (ES) 2012-04-25 EP claimed
US-20120088809-A1 1-(2-ALKYL-2,3-DIHYDRO-BENZOFURAN-4-YL)-PYRROLIDIN-3-YLAMINE ACYL COMPOUNDS FERRER INTERNACIONAL, S.A. (ES) 2012-04-12 US claimed
EP-2443108-A1 1-(2-ALKYL-2,3-DIHYDRO-BENZOFURAN-4-YL)-PYRROLIDIN-3-YLAMINE ACYL COMPOUNDS Ferrer Internacional, S.A. (ES) 2012-04-25 EP disclosed
US-20120088809-A1 1-(2-ALKYL-2,3-DIHYDRO-BENZOFURAN-4-YL)-PYRROLIDIN-3-YLAMINE ACYL COMPOUNDS FERRER INTERNACIONAL, S.A. (ES) 2012-04-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120088809-A1 1-(2-ALKYL-2,3-DIHYDRO-BENZOFURAN-4-YL)-PYRROLIDIN-3-YLAMINE ACYL COMPOUNDS MTNR1A, MTNR1B, TPH2 GAA 3213/4885HPGD 1351/4885SMN1; SMN2 1180/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.